Psomagen, Inc. Partners with Swift Biosciences to Fill the Increasing Need for Genomic Surveillance of SARS-CoV-2 Variants

ROCKVILLE, MD — April 13 2021 — Psomagen, Inc., a US-based genetic sequencing and data analysis service provider, is collaborating with Swift Biosciences (now part of Integrated DNA Technologies), a pioneer in the development of research-use-only library preparation kits, to offer comprehensive SARS-CoV-2 variant determination using next-generation sequencing (NGS). Early in the pandemic, public health […]

A Look into Plant DNA Analysis at the Schnable Lab in Nebraska

CUSTOMER SPOTLIGHT MEET THE SCHNABLE LAB As our population grows and climate changes, the importance of creating high-yield crops to feed the world increases. Join us as we get to know the Schnable Lab, based at the University of Nebraska-Lincoln, about their efforts to isolate DNA from available plant material to create sturdier and higher-yielding […]

Psomagen, Inc. Expands Precision Genomics Capabilities with 10x Genomics’ Single Cell Sequencing Technologies

ROCKVILLE, MD — February 23, 2021 — Psomagen, Inc., a US-based genetic sequencing and data analysis service provider, is proud to expand its next-generation sequencing capabilities to include end-to-end single cell sequencing (SCS) services. These services, which include gene expression and single cell immune profiling, are powered by the Chromium platform and Next GEM-based technology […]

COVID-19 Testing Industry Consortium Survey Helps Us Understand Pandemic’s Challenges

As one of the newest members of the COVID-19 Testing Industry Consortium, we wanted to share with you the results of our Back-to-Work survey. The survey, conducted last fall,  represents the experiences of 77 organizations across the United States. We hope the information inside will help us understand the intricacies of the ongoing pandemic challenges […]

Methods of Detecting COVID-19

It seems like eons ago that the nation saw its first cases of COVID-19. In the early stages of the outbreak, the coronavirus was all anyone could talk about. Questions like, “How infectious is it?”, “What are the symptoms?”, and, “Who is at risk?” were at the forefront of our thoughts and conversations.  As time […]

How Can Genetics Help Predict Diseases?

If you could unravel your DNA and see if your genes indicate a high risk for certain diseases, would you do it? What if this knowledge meant you could make lifestyle changes and reduce your risk? Genomic medicine makes this possible, and it’s opening up an entire world of possibilities for our health. Computer technology […]

The Role of Genes in the Severity of COVID-19 Symptoms

The new strain of coronavirus known as SARS-CoV-2 or COVID-19 is a highly contagious yet highly selective respiratory virus that continues to puzzle researchers and medical professionals. At first, it seemed as though only the elderly and those with underlying health conditions were at risk of developing severe symptoms and dying from the virus — […]

The Viral Evolution of COVID-19

To the knowledge of scientists and the CDC, the family of coronaviruses has been around since the mid-1960s. One of the most deadly of these viruses came about in the early 2000s when Severe Acute Respiratory Syndrome, otherwise known as SARS, emerged in China. A decade later, the Middle East Respiratory Syndrome (MERS) developed in […]

Psomagen COVID-19 Update

To the Psomagen Clients: During the past few weeks, the world has been massively impacted by the coronavirus (COVID-19). We are constantly aware of the updates and decisions that are happening with the coronavirus through the CDC, WHO, and local news channels. While we are being cautious, we remain fully operational to ensure that our clients have […]

Our Latest Publications

We are proud to share the many number of valuable publications that we have released over the years. Feel free to read below to see what we have been working on and discovering since 2004. 2016 Jeong-Sun Seo et al. De novo assembly and phasing of a Korean human genome. Nature 538, 243-247 (2016). 2012 […]